APO RESEARCH · REPORT
Allergy Immunotherapy
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
Product & engineering
Understand the product.
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
Selected research
Industry Research
Allergy Immunotherapy Industry Research Report 2026
Market perspective
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
In EMEA, Allergy Immunotherapy main players include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, Holister Stier, Leti, etc., totally accounting for about 98% of market. As for the types of products, it can be divided into Subcutaneous Immunotherapy and Sublingual Immunotherapy. The most common product is Subcutaneous Immunotherapy, with a share over 60%. In terms of applications, it is widely used in Allergic Rhinitis, Allergic Asthma and Others. The most application is in Allergic Rhinitis, with a share over 45%.
Read the full market overview
Report Scope
This report quantifies the global Allergy Immunotherapy market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Allergy Immunotherapy Market by Company
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
Holister Stier
Leti
Allergy Immunotherapy Segment by Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Allergy Immunotherapy Segment by Application
Allergic Rhinitis
Allergic Asthma
Others
Allergy Immunotherapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allergy Immunotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Allergy Immunotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allergy Immunotherapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Allergy Immunotherapy manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Allergy Immunotherapy by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Allergy Immunotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Subcutaneous Immunotherapy
- Sublingual Immunotherapy
Applications
- Allergic Rhinitis
- Allergic Asthma
- Others
Companies covered
- ALK-Abello
- Stallergenes Greer
- Merck
- Allergy Therapeutics
- HAL
- Holister Stier
- Leti
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Allergy Immunotherapy Market Size (2021-2032)
- 2.2.2 Global Allergy Immunotherapy Sales (2021-2032)
- 2.2.3 Global Allergy Immunotherapy Market Average Price (2021-2032)
- 2.3 Allergy Immunotherapy by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Subcutaneous Immunotherapy
- 2.3.3 Sublingual Immunotherapy
- 2.4 Allergy Immunotherapy by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Allergic Rhinitis
- 2.4.3 Allergic Asthma
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Allergy Immunotherapy Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Allergy Immunotherapy Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Allergy Immunotherapy Revenue of Manufacturers (2021-2026)
- 3.4 Global Allergy Immunotherapy Average Price by Manufacturers (2021-2026)
- 3.5 Global Allergy Immunotherapy Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Allergy Immunotherapy, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Allergy Immunotherapy, Product Type & Application
- 3.8 Global Manufacturers of Allergy Immunotherapy, Established Date
- 3.9 Global Allergy Immunotherapy Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 ALK-Abello
- 4.1.1 ALK-Abello Company Information
- 4.1.2 ALK-Abello Business Overview
- 4.1.3 ALK-Abello Allergy Immunotherapy Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 ALK-Abello Allergy Immunotherapy Product Portfolio
- 4.1.5 ALK-Abello Recent Developments
- 4.2 Stallergenes Greer
- 4.2.1 Stallergenes Greer Company Information
- 4.2.2 Stallergenes Greer Business Overview
- 4.2.3 Stallergenes Greer Allergy Immunotherapy Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Stallergenes Greer Allergy Immunotherapy Product Portfolio
- 4.2.5 Stallergenes Greer Recent Developments
- 4.3 Merck
- 4.3.1 Merck Company Information
- 4.3.2 Merck Business Overview
- 4.3.3 Merck Allergy Immunotherapy Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Allergy Immunotherapy Product Portfolio
- 4.3.5 Merck Recent Developments
- 4.4 Allergy Therapeutics
- 4.4.1 Allergy Therapeutics Company Information
- 4.4.2 Allergy Therapeutics Business Overview
- 4.4.3 Allergy Therapeutics Allergy Immunotherapy Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Allergy Therapeutics Allergy Immunotherapy Product Portfolio
- 4.4.5 Allergy Therapeutics Recent Developments
- 4.5 HAL
- 4.5.1 HAL Company Information
- 4.5.2 HAL Business Overview
- 4.5.3 HAL Allergy Immunotherapy Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 HAL Allergy Immunotherapy Product Portfolio
- 4.5.5 HAL Recent Developments
- 4.6 Holister Stier
- 4.6.1 Holister Stier Company Information
- 4.6.2 Holister Stier Business Overview
- 4.6.3 Holister Stier Allergy Immunotherapy Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Holister Stier Allergy Immunotherapy Product Portfolio
- 4.6.5 Holister Stier Recent Developments
- 4.7 Leti
- 4.7.1 Leti Company Information
- 4.7.2 Leti Business Overview
- 4.7.3 Leti Allergy Immunotherapy Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Leti Allergy Immunotherapy Product Portfolio
- 4.7.5 Leti Recent Developments
5 Global Allergy Immunotherapy Market Scenario by Region
- 5.1 Global Allergy Immunotherapy Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Allergy Immunotherapy Sales by Region: 2021-2032
- 5.2.1 Global Allergy Immunotherapy Sales by Region: 2021-2026
- 5.2.2 Global Allergy Immunotherapy Sales by Region: 2027-2032
- 5.3 Global Allergy Immunotherapy Revenue by Region: 2021-2032
- 5.3.1 Global Allergy Immunotherapy Revenue by Region: 2021-2026
- 5.3.2 Global Allergy Immunotherapy Revenue by Region: 2027-2032
- 5.4 North America Allergy Immunotherapy Market Facts & Figures by Country
- 5.4.1 North America Allergy Immunotherapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Allergy Immunotherapy Sales by Country (2021-2032)
- 5.4.3 North America Allergy Immunotherapy Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Allergy Immunotherapy Market Facts & Figures by Country
- 5.5.1 Europe Allergy Immunotherapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Allergy Immunotherapy Sales by Country (2021-2032)
- 5.5.3 Europe Allergy Immunotherapy Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Allergy Immunotherapy Market Facts & Figures by Country
- 5.6.1 Asia Pacific Allergy Immunotherapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Allergy Immunotherapy Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Allergy Immunotherapy Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Allergy Immunotherapy Market Facts & Figures by Country
- 5.7.1 South America Allergy Immunotherapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Allergy Immunotherapy Sales by Country (2021-2032)
- 5.7.3 South America Allergy Immunotherapy Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Allergy Immunotherapy Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Allergy Immunotherapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Allergy Immunotherapy Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Allergy Immunotherapy Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Allergy Immunotherapy Sales by Type (2021-2032)
- 6.1.1 Global Allergy Immunotherapy Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Allergy Immunotherapy Sales Market Share by Type (2021-2032)
- 6.2 Global Allergy Immunotherapy Revenue by Type (2021-2032)
- 6.2.1 Global Allergy Immunotherapy Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Allergy Immunotherapy Revenue Market Share by Type (2021-2032)
- 6.3 Global Allergy Immunotherapy Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Allergy Immunotherapy Sales by Application (2021-2032)
- 7.1.1 Global Allergy Immunotherapy Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Allergy Immunotherapy Sales Market Share by Application (2021-2032)
- 7.2 Global Allergy Immunotherapy Revenue by Application (2021-2032)
- 7.2.1 Global Allergy Immunotherapy Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Allergy Immunotherapy Revenue Market Share by Application (2021-2032)
- 7.3 Global Allergy Immunotherapy Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Allergy Immunotherapy Value Chain Analysis
- 8.1.1 Allergy Immunotherapy Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Allergy Immunotherapy Production Mode & Process
- 8.2 Allergy Immunotherapy Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Allergy Immunotherapy Distributors
- 8.2.3 Allergy Immunotherapy Customers
9 Global Allergy Immunotherapy Analyzing Market Dynamics
- 9.1 Allergy Immunotherapy Industry Trends
- 9.2 Allergy Immunotherapy Industry Drivers
- 9.3 Allergy Immunotherapy Industry Opportunities and Challenges
- 9.4 Allergy Immunotherapy Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst